NVO
USDNovo Nordisk A/S Common Stock
$45.700-0.520 (-1.125%)
即時價格
Healthcare
Drug Manufacturers - General
丹麥
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$46.220
最高
$46.360
最低
$45.570
交易量
37.86M
公司基本面
市值
210.1B
行業
Drug Manufacturers - General
國家
Denmark
交易統計
平均交易量
15.16M
交易所
NYQ
貨幣
USD
52週範圍
最低 $45.05當前 $45.700最高 $112.52
相關新聞
CNBC
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer
The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.
查看更多
CNBC
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market.
查看更多
CNBC
November trading, Berkshire's cash hoard, Big Tech's ad revenue and more in Morning Squawk
Here are five key things investors need to know to start the trading day.
查看更多
CNBC
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound
Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery.
查看更多
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。